APPLICATIONS PUBLISHED 20 NOVEMBER 2002

Published: 1-May-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492

  • Electronic alarm timer for use with a medical regimen
    Akzo Nobel 1257244*

  • Protection of the female reproductive system from natural and artificial insults
    Sloan-Kettering Institute for Cancer Research 1257245*

  • Pharmaceutical compsn
    Bentley Pharmaceuticals 1257248*

  • Formulations containing an anti-cholinergic drug for the treatment of chronic obstructive pulmonary disease
    Cheisi Farmaceutici 1257254*

  • Therapeutic product, use and formulation thereof
    Advanced Pharma 1257255*

  • Drug carrier pellet production process
    Alpharma 1257256*

  • Delivery systems using preformed biodegradable polymer compsns and methods
    3M Innovative Properties 1257257*

  • Bioadhesive compsn
    National Starch and Chemical Treatment Investment Holding Corp 1257258*

  • Controlled release ceramic particles, compsns thereof, processes of preparation and methods of use
    Australian Nuclear Science and Technology Organisation 1257259*

  • Powder formulation for inhalation
    Rijksuniversiteit te Groningen 1257260*

  • Antiviral pharmaceutical compsns containing iron chelators
    Faculteit Geneeskunde Universiteit Utrecht 1257261*

  • Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
    Novactyl 1254262*

  • Microcompetition and human disease
    SCI Pharmaceuticals 1254263*

  • Estrogen receptor modulators
    Merck & Co 1257264*

  • Use of 2-phenylene diamine derivatives for the treatment of infections
    Jomaa Pharmaka 1257265*

  • Intravenous carnitine for the treatment of chronic uraemic patients undergoing periodic dialysis
    Sigma-Tau Industrie Farmaceutiche Riunite 1257266*

  • Compsn for the prevention and/or treatment of lipid metabolism disorders and allergic forms
    Sigma-Tau Healthscience 1257267*

  • Diagnostic and therapeutic compsns and methods for affecting tumour growth using oxygen mimetic agents
    Novolytics 1257268*

  • Orally administratable acid stable anti-ulcer benzimidazole derivatives
    Kopran Research Laboratories 1257269*

  • A method for stabilising leflunomide
    Teva Pharmaceutical Industries 1257270*

  • Use of pramipexazole for the treatment of addictive disorders
    Pharmacia & Upjohn 1257271*

  • Thiazolium compounds and treatments of disorders associated with protein aging
    Alteon 1257272*

  • Improved treatment for acute physical insult to the central nervous system
    University of Saskatchewan Technologies 1257273*

  • Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid for treating infectious diseases
    Susilo, Rudy 1257274*

  • Use of central cannabinoid receptors antagonist for preparing medicines designed to facilitate smoking cessation
    Sanofi-Synthelabo 1257275*

  • Antiviral azaindole derivatives
    Bristol-Myers Squibb 1257276*

  • New drug combinations comprising a norepinephrine reuptake inhibitor and a antimuscarinic agent
    Pharmacia & Upjohn 1257277*

  • The use of mirtazepine for the treatment of sleep disorders
    Akzo Nobel 1257278*

  • Improvement of implantation rate using FF-MAS
    Schering 1257279*

  • Drospirenone for hormone replacement therapy
    Schering 1257280*

  • Nucleoside analogues with carboxamidine modified monocyclic base
    ICN Pharmaceuticals 1257281*

  • Pancreatic stem cells and their use in transplantation
    The General Hospital Corp 1257282*

  • Compsns suitable for oral administration and kits and methods thereof for hydrating mammalian skin
    Procter & Gamble 1257283*

  • A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
    The Regents of the University of California 1257284*

  • Use of breast cancer associated membrane proteins (BCMO) for treatment, prophylaxis and diagnosis of breast cancer
    Oxford Glycosciences (UK) 1257285*

  • Cancer treatment and prodrugs involving HES-1 protein
    Karo Bio 1257286*

  • Compsns and methods for the early diagnosis of ovarian cancer
    The Board of Trustees of the University of Arkansas 1257287*

  • Methods for regulating IL-10 with IL-9, and applications thereof
    Ludwig Institute for Cancer Research 1257288*

  • Immunotherapy using interleukin 13 receptor subunit alpha 2
    The Penn State University Foundation 1257289*

  • Method for antigen-specific stimulation of T-lymphocytes with synthetic peptide libraries
    Kern, Florian 1257290*

  • Novel antibody with specificity for colon cancer
    Active Biotech 1257291*

  • Use of IL-18 inhibitors
    Applied Research Systems Holding; Yeda Research and Development Company 1257292*

  • Immunomodulatory effective compounds, methods for the production thereof and their use
    Kleine & Stube Endotoxin 1257293*

  • Carrier particles for drug delivery and process for their preparation
    Ottowa Heart Institute Research Corporation 1257294*

  • Factor VII or VIIA-type molecules
    Maxygen Aps; Maxygen Holdings 1257295*

  • Caspase activated prodrugs therapy
    Genentech 1257296*

  • Compsns and methods for treatment of angiogenesis in pathological lesions
    Philogen 1257297*

  • Cosmid DNA constructs and methods of making and using the same
    The Trustees of the University of Pennsylvania 1257298*

  • Radioactive therapeutic liposomes
    Anticancer Therapeutic Inventions 1257299*

  • A process for the preparation of salts of L-carnitine and alkanoyl L-carnitine with mucic acid
    Sigma-Tau Industrie Farmaceutiche Riunite 1257524*

  • Stabilising agent for hydroxylamine solutions
    BASF 1257525*

  • Aniline-derived ligands for the thyroid receptor
    Bristol-Myers Squibb 1257526*

  • (2S)-aminoindan derivatives, a process for their preparation, and their use as selective dopamine D3 ligands
    Pharmacia & Upjohn 1257527*

  • Aminoalcohol derivatives
    Fujisawa Pharmaceuticals 1257528*

  • Method for producing nitroguanidine
    Dynamit Nobel GmbH Explosivstoff- und Systemtechnik 1257529*

  • Aminosulfonylbiphenyl derivatives
    Merck Patent 1257530*

  • Method for the preparation of carbothioic acids
    Abbott Laboratories 1257531*

  • Process for the preparation of (e)-caprolactam
    DSM 1257532*

  • New coupling process
    AstraZeneca 1257533*

  • Novel process for preparing 4-substituted-1H-pyrrole-3-carboxylic acid ester
    LG Chem Investment 1257534*

  • Substituted pyridine compounds useful for controlling chemical synaptic transmission
    Abbott Laboratories 1257535*

  • Substituted nicotinamides and analogues as activators of caspases and inducers of apoptosis and the use thereof
    Cytovia 1257536*

  • Therapeutic morpholino-substituted compounds
    Kinacia 1257537*

  • 9-alkylamino-1-nitroacridine derivatives
    New York Medical College 1257538*

  • Amino pyrazole derivatives useful for the treatment of obesity and other disorders
    Ortho-McNeill Pharmaceuticals 1257539*

  • Method for the production of 1-amino-3-aryl-uracils
    Bayer 1257540*

  • Method for producing 2-(1,2,4-traizol-1-yl)-ethanols
    Bayer 1257542*

  • Pyridinylimidazoles
    SmithKline Beecham 1257543*

  • Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
    Vertex Pharmaceuticals 1257544*

  • Selective IGLUR 5 receptor antagonists
    Eli Lilly 1257545*

  • Kinase inhibitors
    Amgen 1257546*

  • 1,3-disubstituted pyrrolidines as alpha-2-adrenoreceptor antagonists
    Novartis 1257547*

  • Benzofuran carboxamides and their therapeutic use
    Darwin Discovery 1257548*

  • Matrix metalloproteinase inhibitors and uses thereof
    Bristol-Myers Squibb Pharma 1257549*

  • Platelet ADP receptor inhibitors
    COR Therapeutics 1257550*

  • Heterocyclic compounds and their use as PARP inhibitors
    BASF 1257551*

  • Xanthine derivatives, intermediates and use for treating osteoporosis
    Aventis Pharma 1257552*

  • Pyrrolopyrimidinone derivatives, process of preparation and use
    SK Chemicals; In2gen 1257553*

  • Benzoxathiepino(3,4-B)bipyridine derivatives, process for their preparation and their use as medicaments
    Ortho-McNeill Pharmaceutical 1257554*

  • Pyrimidine compounds and their use as modulators of chemokine receptor activity
    AstraZeneca 1257555*

  • Thiazolopyrimidines and their use as modulators of chemokine receptoractivity
    AstraZeneca 1257556*

  • Method for producing N-(phosphonomethyl)glycine
    Degussa 1257557*

  • Methods for synthesis of alpha-D-gal (1,3) gal-containing oligosaccharides
    Alchemica 1257558*

  • Mammalian sphingosine-1-phosphate phosphatase
    Merck 1257559*

  • BCL-2-like polynucleotides, polypeptides, and antibodies
    Human Genome Sciences 1257560*

  • Staphylococcyl GTPase OBGcleotide sequence encoding staphylococcyl GTP-binding protein
    Anadys Pharmaceuticals 1257561*
  • You may also like